BiotechTube
Home/Pipeline/Future Molecular POC Tests

Future Molecular POC Tests

Not Specified

Research/Pre-clinicalActive

Key Facts

Indication
Not Specified
Phase
Research/Pre-clinical
Status
Active
Company
Biocrucible

About Biocrucible

Sapphiros is a private, commercial-stage diagnostics company positioned to disrupt global health testing through scalable, low-cost technology platforms. The company has secured significant strategic partnerships, including a major supply agreement with Roche and a development contract with BARDA, validating its manufacturing capability and product pipeline. With a leadership team boasting deep industry experience and a UK-based facility capable of producing five billion units annually, Sapphiros aims to redefine everyday health management by moving testing out of labs and into consumers' hands.

View full company profile

Therapeutic Areas

Infectious DiseasePublic Health

Other Not Specified Drugs

DrugCompanyPhase
FL116Forlong BiotechnologyNot specified
FL117Forlong BiotechnologyNot specified
FL118Forlong BiotechnologyNot specified
FL301Forlong BiotechnologyNot specified
JSKN016AlphaMab OncologyPhase 1
JSKN033AlphaMab OncologyPhase 1
JSKN022AlphaMab OncologyPhase 1
JSKN027AlphaMab OncologyPhase 1
KN019AlphaMab OncologyPhase 1
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
SR2162SIMR (Australia) BiotechIND Approved